(Reuters) - The biopharmaceutical company said sales of clindamycin, used to treat serious infections, exceeded $16 million in the United States in 2006.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment